Drug intelligence / Profile preview

adenosine-2,3-dialdehyde

Development stage
Preclinical
Modality
Small Molecules
Administration
Subcutaneous, Intraperitoneal
01

Overview

Adenosine-2,3-dialdehyde, commonly referred to as AdOx, is a potent and irreversible inhibitor of S-adenosylhomocysteine (SAH) hydrolase (adenosylhomocysteinase). By blocking the activity of SAH hydrolase, AdOx prevents the breakdown of SAH into adenosine and homocysteine, leading to a significant intracellular accumulation of SAH. Because SAH is a powerful competitive inhibitor of S-adenosylmethionine (SAM)-dependent methyltransferases, its buildup results in the broad suppression of biological methylation processes, including the methylation of DNA, RNA, and proteins. In biomedical research, AdOx is extensively utilized as a pharmacological tool to study the regulatory roles of methylation in diverse cellular processes such as T-cell activation, viral replication, and epigenetic gene regulation. It is primarily characterized as a research reagent and has not been developed for clinical therapeutic use in humans.

Other names
Periodate-oxidized adenosineAdenosine, 2',3'-dialdehyde2',3'-dialdehyde adenosine
02

Targets

AHCY (S-adenosylhomocysteine hydrolase)

Beyond the preview

Go deeper on adenosine-2,3-dialdehyde.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adenosine-2,3-dialdehyde.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call